These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9040027)

  • 1. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
    Tanaka T; Sohmiya K; Kawamura K
    J Mol Cell Cardiol; 1997 Jan; 29(1):121-7. PubMed ID: 9040027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36 deficiency has little influence on the pathophysiology of hypertrophic cardiomyopathy.
    Nakamura T; Sugihara H; Inaba T; Kinoshita N; Adachi Y; Hirasaki S; Matsuo A; Azuma A; Nakagawa M
    J Mol Cell Cardiol; 1999 Jun; 31(6):1253-9. PubMed ID: 10371699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant familial cardiomyopathy with sudden death, typical asymmetric septal hypertrophy and dilated cardiomyopathy-like features].
    Seo T; Yokota Y; Maehashi N; Takarada A; Kubo M; Toh S; Nakanishi O; Masuda J; Fujitani K; Fukuzaki H
    J Cardiogr; 1986 Mar; 16(1):81-94. PubMed ID: 3782892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic cardiomyopathy manifesting different modes of illness: report of three cases].
    Shida M; Miyazaki Y; Matsuyama K; Iwami G; Ooga M; Chiba M; Furuta Y; Toshima H; Koga Y
    J Cardiol; 1987 Mar; 17(1):187-97. PubMed ID: 3429921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy.
    Okamoto F; Tanaka T; Sohmiya K; Kawamura K
    Jpn Circ J; 1998 Jul; 62(7):499-504. PubMed ID: 9707006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular aspects of cardiac hypertrophy and their implications in cardiomyopathies].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):223-7. PubMed ID: 10885318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different patterns of 123I-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency].
    Watanabe K; Toba K; Ogawa Y; Aizawa Y; Tanabe N; Miyajima S; Kusano Y; Nagatomo T; Hirokawa Y
    Kaku Igaku; 1997 Dec; 34(12):1125-30. PubMed ID: 9494334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.
    Olson TM; Doan TP; Kishimoto NY; Whitby FG; Ackerman MJ; Fananapazir L
    J Mol Cell Cardiol; 2000 Sep; 32(9):1687-94. PubMed ID: 10966831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary atypical hypertrophy: hypertrophic cardiomyopathy with acquired risk factors (author's transl)].
    Koga Y; Itaya K; Toshima H
    J Cardiogr; 1981 Dec; 11(4):1063-75. PubMed ID: 7201489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unclassified cardiomyopathies: subspecies and their transformation].
    Ikeda Y; Kawai S; Okada R; Yamaguchi H
    J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertrophic cardiomyopathy showing no 123I-BMIPP myocardial accumulation with type I CD36 deficiency].
    Watanabe K; Miyajima S; Kusano Y; Tanabe N; Hirokawa Y
    Kaku Igaku; 1997 Jul; 34(7):481-6. PubMed ID: 9293711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel locus for an inherited cardiomyopathy maps to chromosome 7.
    Song L; DePalma SR; Kharlap M; Zenovich AG; Cirino A; Mitchell R; McDonough B; Maron BJ; Seidman CE; Seidman JG; Ho CY
    Circulation; 2006 May; 113(18):2186-92. PubMed ID: 16651466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy with type I CD36 deficiency.
    Watanabe K; Toba K; Ogawa Y; Kodama M; Hirono S; Ohkura Y; Hanawa H; Nakamura Y; Aoki Y; Fuse I; Aizawa Y; Miyajima S; Kusano Y; Nagatomo T; Hasegawa G; Naito M
    Jpn Circ J; 1998 Jul; 62(7):541-2. PubMed ID: 9707013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
    Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
    J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of development of asymmetric septal hypertrophy in patients with essential systemic hypertension.
    Yokota Y; Teng SS; Emoto R; Miki T; Takarada A; Seo T; Sano H; Fukuzaki H
    Jpn Circ J; 1989 Oct; 53(10):1173-84. PubMed ID: 2533275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.